Skip to main content

and
  1. Article

    Open Access

    Impact of Bacteria Types on the Clinical Outcomes of Spontaneous Bacterial Peritonitis

    Cirrhotic patients presenting with spontaneous bacterial peritonitis (SBP) have elevated risk of short-term mortality. While high Model for End-Stage Liver Disease-Sodium score (MELD-Na) and ascites culture yi...

    Cameron Furey, Selena Zhou, Joo Hye Park, Andrew Foong in Digestive Diseases and Sciences (2023)

  2. Article

    Patient perspectives on window of opportunity clinical trials in early-stage breast cancer

    Window of opportunity trials (WOT) are increasingly common in oncology research. In WOT participants receive a drug between diagnosis and anti-cancer treatment, usually for the purpose of investigating that dr...

    Divya A. Parikh, Lisa Kody, Susie Brain in Breast Cancer Research and Treatment (2022)

  3. Article

    The WISDOM study: a new approach to screening can and should be tested

    Laura Esserman, Martin Eklund, Laura van’t Veer in Breast Cancer Research and Treatment (2021)

  4. Article

    Open Access

    Deep learning networks find unique mammographic differences in previous negative mammograms between interval and screen-detected cancers: a case-case study

    To determine if mammographic features from deep learning networks can be applied in breast cancer to identify groups at interval invasive cancer risk due to masking beyond using traditional breast density meas...

    Benjamin Hinton, Lin Ma, Amir Pasha Mahmoudzadeh, Serghei Malkov, Bo Fan in Cancer Imaging (2019)

  5. No Access

    Article

    IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo

    Interleukin-17E (IL-17E) belongs to a novel family of cytokines that possess significant homology to IL-17. IL-17E has potent inflammatory effects in vitro and in vivo. Overexpression of IL-17E in mice results...

    Tania Benatar, Ming Y. Cao, Yoon Lee, Jeff Lightfoot in Cancer Immunology, Immunotherapy (2010)

  6. No Access

    Article

    Virulizin® induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors

    Virulizin® has demonstrated strong antitumor efficacy in a variety of human tumor xenograft models including melanoma, pancreatic cancer, breast cancer, ovarian cancer and prostate cancer. Our previous studies ha...

    Tania Benatar, Ming Y. Cao, Yoon Lee, Hui Li in Cancer Immunology, Immunotherapy (2008)

  7. No Access

    Article

    Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages

    Virulizin, a novel biological response modifier, has demonstrated significant antitumor efficacy in a variety of human tumor xenograft models including melanoma, pancreatic cancer, breast cancer, ovarian cance...

    Hui Li, Ming Y. Cao, Yoon Lee, Vivian Lee in Cancer Immunology, Immunotherapy (2005)

  8. No Access

    Article

    NK cell activation and tumor infiltration are involved in the antitumor mechanism of Virulizin

    Previous studies have demonstrated antitumor efficacy of Virulizin in several human tumor xenograft models and a critical role for macrophages in the antitumor mechanism of Virulizin. Although there is growing...

    Ming Yu Cao, Yoon Lee, Ning** Feng, Hui Li, Caigan Du in Cancer Immunology, Immunotherapy (2005)